Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-Current Debt
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Deferred Taxes: 2020-2024

Historic Deferred Taxes for CureVac N.V (CVAC) over the last 1 years, with Jun 2024 value amounting to -$432,909.

  • CureVac N.V's Deferred Taxes fell 1372.43% to -$432,909 in Q2 2024 from the same period last year, while for Jun 2024 it was -$523,326, marking a year-over-year decrease of 3726.27%. This contributed to the annual value of -$123,733 for FY2023, which is 3131.94% down from last year.
  • CureVac N.V's Deferred Taxes amounted to -$432,909 in Q2 2024, which was down 6,741.57% from $6,518 recorded in Q1 2024.
  • In the past 5 years, CureVac N.V's Deferred Taxes ranged from a high of $112.6 million in Q4 2021 and a low of -$119.4 million during Q3 2021.
  • In the last 3 years, CureVac N.V's Deferred Taxes had a median value of -$19,055 in 2023 and averaged -$67,125.
  • Per our database at Business Quant, CureVac N.V's Deferred Taxes surged by 9,258.93% in 2021 and then slumped by 1,372.43% in 2024.
  • Quarterly analysis of 5 years shows CureVac N.V's Deferred Taxes stood at -$1.2 million in 2020, then soared by 9,258.93% to $112.6 million in 2021, then slumped by 100.04% to -$45,911 in 2022, then plummeted by 92.17% to -$88,227 in 2023, then slumped by 1,372.43% to -$432,909 in 2024.
  • Its Deferred Taxes stands at -$432,909 for Q2 2024, versus $6,518 for Q1 2024 and -$88,227 for Q4 2023.